Bone Marrow Cell Culture for Producing Tissue Engineered Regenerative Blood Vessels as a Goal of Clinical Application

骨髓细胞培养生产组织工程再生血管作为临床应用的目标

• 批准号: 14580812
• 负责人: ISHIDA Atsushi
• 金额: $ 2.24万
• 依托单位: Chiba University
• 依托单位国家: 日本
• 项目类别: Grant-in-Aid for Scientific Research (C)
• 财政年份: 2002
• 资助国家: 日本
• 起止时间: 2002 至 2003
• 项目状态: 已结题
• 来源: https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-14580812/
• 关键词: Bone Marrow Cell; CD34 positive cells; Peripheral Blood MNC; Growth Factor; Artificial ECM; Fibronectin; PTFE; Tissue Engineering; VEGF

1.Determination of effective and simple cell-groups sorting for vessel regeneration from bone marrow cells : Aiming at clinical applications, based on recent other research data, G-CSF mobilized peripheral-blood mononuclear cells are thought to be substituted for "cell-groups for vessel regeneration from bone marrow cells" and used for experiment "2"2.Determination of optimal conditions for making "vascular sheets" shortly In vitrocombining three inevitable elements, bone marrow cells, growth factors and artificial extracellular matrix (ECM) for vessel regeneration : Main theme of this study. Endothelial colonization of bone marrow derived CD34 positive cells in culture plates was observed in the media with type I & IV Collagen, Fibronectin, Vitronectin and Fibrinogen as ECM. It was obtained at 1st year that efficacy of Fibronectin was 5 times of those of other ECM. At 2nd year, aiming at further ex vivo vessel regeneration with 3 dimensional culture, one of clinically used vascular prosthesis, PTFE (Polytetrafluoroethylene) sheets, were used for cell culture "scaffold" after coating with PAU (Polyaminourethane) to make hydrophilic and to increase tissue affinity, Bone marrow derived CD34 positive cells and G-CSF mobilized peripheral-blood mononuclear cells were used. Six ECM, type I & IV Collagen, Fibronectin, 2 Fibronectin peptide and Vitronectin were used for observation of acceleration of cell adhesion and proliferation in 3 dimensional culture system Among them, Fibronectin RGD peptide was most efficient.3.To analyze the mechanism of transdifferenciation between endothelial cells and smooth muscle cells in "vascular sheets" It remains to be unclear.

1.确定有效且简单的骨髓细胞血管再生细胞群分选：针对临床应用，根据最近的其他研究数据，G-CSF动员的外周血单个核细胞被认为可以替代“细胞群”用于从骨髓细胞再生血管”并用于实验“2”2.确定短期内制造“血管片”的最佳条件在体外结合三种不可避免的元素，骨髓细胞，生长因子和人工用于血管再生的细胞外基质（ECM）：本研究的主题。在含有 I 型和 IV 型胶原、纤连蛋白、玻连蛋白和纤维蛋白原作为 ECM 的培养基中观察到培养板中骨髓来源的 CD34 阳性细胞的内皮定植。第一年就发现纤连蛋白的功效是其他ECM的5倍。第二年，为了通过三维培养进一步离体血管再生，临床使用的血管假体之一PTFE（聚四氟乙烯）片材在涂上PAU（聚氨基聚氨酯）以使其具有亲水性并增加细胞培养“支架”后，被用作细胞培养“支架”。组织亲和力，使用骨髓来源的CD34阳性细胞和G-CSF动员的外周血单核细胞。使用六种ECM、I型和IV型胶原蛋白、纤连蛋白、2纤连蛋白肽和玻连蛋白在3维培养系统中观察细胞粘附和增殖的加速，其中纤连蛋白RGD肽最有效。3.分析转分化的机制内皮细胞和平滑肌细胞之间的“血管片”尚不清楚。

项目成果

石田厚: "ハイブリッド型人工血管の開発のため、骨髄由来内皮前駆細胞が生着・増殖に効果的な多孔質ポリ4フッ化エチレン樹脂(ePTFE)人工マトリックスの開発"千葉医学雑誌(0303-5476). 79巻・6号. 265 (2003)

Atsushi Ishida：“开发一种多孔聚四氟乙烯树脂（ePTFE）人工基质，可有效促进骨髓源性内皮祖细胞的植入和增殖，从而开发混合人工血管”《千叶医学杂志》（0303-5476）。第 79 卷第 6 期。265 (2003)

Ishida, A.: "Development of Polytetrafluoroethylene (PTFE) artificial Matrix for effective adhesion and proliferation of Bone Marrow derived Endothelial Progenitor Cells to produce Hybrid-type prosthetic vascular graft"Journal of the Chiba Medical Society

Ishida, A.：“开发聚四氟乙烯 (PTFE) 人工基质，使骨髓源性内皮祖细胞有效粘附和增殖，以生产混合型人工血管移植物”千叶医学会杂志

石田厚, 今牧瑞浦, 宮崎勝: "ハイブリッド型人工血管の開発のため、骨髄由来内皮前駆細胞が生着・増殖に効果的なPTFE人工matrixの開発"日本血管外科学会雑誌(0918-6778). 12巻・3号. 312 (2003)

Atsushi Ishida、Mizuura Imamaki、Masaru Miyazaki：“开发一种 PTFE 人造基质，可有效促进骨髓源性内皮祖细胞的植入和增殖，从而开发混合人造血管”日本血管外科学会杂志（ 0918-6778) )。第 12 卷，第 3 期。312 (2003)。

石田厚: "ハイブリッド型人工血管の開発のため、骨髄由来内皮前駆細胞が生着・増殖に効果的な多孔質ポリ4フッ化エチレン樹脂(ePTFE)人工マトリックスの開発"千葉医科雑誌(0303-5476). 79巻・6号. 265 (2003)

Atsushi Ishida：“开发一种多孔聚四氟乙烯树脂（ePTFE）人工基质，可有效促进骨髓源性内皮祖细胞的植入和增殖，从而开发混合人工血管”《千叶医学杂志》（0303-5476）。第 79 卷第 6 期。265 (2003)

Ishida, A., Imamaki, M., Hirano, M., Masuda, M., Miyazaki, M.: "Bone Marrow Cell Culture for therapeutic angiogenesis with cell implantation as a clinical application"Journal of Japanese Society for Vascular Surgery. 11-2. 321 (2002)

Ishida, A.、Imamaki, M.、Hirano, M.、Masuda, M.、Miyazaki, M.：“骨髓细胞培养与细胞植入治疗性血管生成的临床应用”日本血管外科学会杂志。